Mary C. Beckerle - Nov 11, 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Nov 11, 2025
Transactions value $
-$897,994
Form type
4
Date filed
11/13/2025, 07:12 PM
Previous filing
May 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Beckerle Mary C Director C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA /s/ Nina Ayer, Attorney in Fact 2025-11-13 0001520181

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $134K +5.78K +14.38% $23.24 46K Nov 11, 2025 Direct F1
transaction EXEL Common Stock Sale -$243K -5.78K -12.57% $42.03 40.2K Nov 11, 2025 Direct F1
transaction EXEL Common Stock Sale -$789K -18.8K -46.84% $41.90 21.4K Nov 11, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -5.78K -25.71% $0.00 16.7K Nov 11, 2025 Common Stock 5.78K $23.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 21,380 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3 The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024.